Herbalife Ltd. (NYSE:HLF – Get Free Report) has earned a consensus recommendation of “Hold” from the five ratings firms that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $9.90.
A number of equities analysts recently weighed in on HLF shares. Mizuho boosted their target price on shares of Herbalife from $8.00 to $9.00 and gave the company a “neutral” rating in a report on Friday, November 1st. Citigroup lowered their price objective on Herbalife from $16.00 to $13.00 and set a “buy” rating for the company in a research report on Friday, October 25th. DA Davidson cut their target price on Herbalife from $13.00 to $7.50 and set a “neutral” rating on the stock in a research report on Thursday, October 31st. B. Riley lowered their target price on Herbalife from $17.00 to $12.00 and set a “buy” rating for the company in a report on Thursday, October 31st. Finally, StockNews.com raised Herbalife from a “hold” rating to a “buy” rating in a research note on Monday, November 4th.
Read Our Latest Analysis on HLF
Insider Buying and Selling
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in the business. GAMMA Investing LLC raised its holdings in shares of Herbalife by 465.3% in the 2nd quarter. GAMMA Investing LLC now owns 3,533 shares of the company’s stock worth $37,000 after acquiring an additional 2,908 shares during the last quarter. nVerses Capital LLC increased its holdings in Herbalife by 240.0% during the 2nd quarter. nVerses Capital LLC now owns 5,100 shares of the company’s stock worth $53,000 after purchasing an additional 3,600 shares in the last quarter. Public Employees Retirement System of Ohio raised its stake in shares of Herbalife by 22.9% in the first quarter. Public Employees Retirement System of Ohio now owns 5,558 shares of the company’s stock worth $56,000 after purchasing an additional 1,035 shares during the last quarter. Van ECK Associates Corp lifted its holdings in shares of Herbalife by 10.3% in the second quarter. Van ECK Associates Corp now owns 8,684 shares of the company’s stock valued at $90,000 after purchasing an additional 808 shares in the last quarter. Finally, Foundry Partners LLC purchased a new position in shares of Herbalife during the first quarter valued at approximately $105,000.
Herbalife Trading Up 2.9 %
Shares of HLF stock opened at $7.93 on Monday. Herbalife has a 1-year low of $6.59 and a 1-year high of $15.66. The stock has a market cap of $799.26 million, a price-to-earnings ratio of 9.33, a PEG ratio of 0.28 and a beta of 1.17. The stock has a 50-day moving average of $7.32 and a 200-day moving average of $9.25.
Herbalife (NYSE:HLF – Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.19 by $0.38. The business had revenue of $1.24 billion during the quarter, compared to the consensus estimate of $1.23 billion. Herbalife had a net margin of 1.73% and a negative return on equity of 18.66%. Sell-side analysts forecast that Herbalife will post 1.51 earnings per share for the current year.
About Herbalife
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
See Also
- Five stocks we like better than Herbalife
- 3 Healthcare Dividend Stocks to Buy
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- How to Capture the Benefits of Dividend Increases
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Airline Stocks – Top Airline Stocks to Buy Now
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.